Home > Insider Trading > Filing (0000899243-20-031267)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1743881	Bridgebio Pharma Inc.	BBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1257809	Frank Mccormick	C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301	Chairman Of Oncology	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-11-13	31,632	$42.22	1,268,836	No	4	S	Direct
Common Stock	Disposition	2020-11-13	58,299	$42.91	1,210,537	No	4	S	Direct
Common Stock	Disposition	2020-11-13	10,069	$43.57	1,200,468	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the weighted average sale price of the shares sold from $41.53 to $42.52 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3 and 4.
Corrects ending balance which was previously overstated by 100 shares in the Reporting Person's Form 4 filings on May 21, 2020 and December 31, 2019.
Represents the weighted average sale price of the shares sold from $42.53 to $43.52 per share.
Represents the weighted average sale price of the shares sold from $43.53 to $43.67 per share.